Effects of strong and moderate CYP3A4 inducers on the pharmacokinetics of fedratinib in healthy adult participants

被引:0
作者
Ken Ogasawara
Jeanelle Kam
Mark Thomas
Liangang Liu
Mary Liu
Yongjun Xue
Sekhar Surapaneni
Leonidas N. Carayannopoulos
Simon Zhou
Maria Palmisano
Gopal Krishna
机构
[1] Bristol Myers Squibb,
[2] Covance Clinical Research Unit,undefined
[3] Inc.,undefined
来源
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词
Fedratinib; Drug–drug interaction; CYP3A4; Inducer; Rifampin; Efavirenz;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:369 / 377
页数:8
相关论文
共 208 条
[91]  
Tefferi A(undefined)undefined undefined undefined undefined-undefined
[92]  
Jamieson C(undefined)undefined undefined undefined undefined-undefined
[93]  
Gabrail NY(undefined)undefined undefined undefined undefined-undefined
[94]  
Lebedinsky C(undefined)undefined undefined undefined undefined-undefined
[95]  
Gao G(undefined)undefined undefined undefined undefined-undefined
[96]  
Liu F(undefined)undefined undefined undefined undefined-undefined
[97]  
Xu C(undefined)undefined undefined undefined undefined-undefined
[98]  
Cao H(undefined)undefined undefined undefined undefined-undefined
[99]  
Talpaz M(undefined)undefined undefined undefined undefined-undefined
[100]  
Wu F(undefined)undefined undefined undefined undefined-undefined